Brodowicz T, Kandioler D, Tomek S, Ludwig C, Rudas M, Kunstfeld R, Koestler W, Hejna M, Budinsky A, Wiltschke C, Zielinski C C
Clinical Division of Oncology, University Hospital, Vienna, Austria.
Br J Cancer. 2001 Nov 30;85(11):1764-70. doi: 10.1054/bjoc.2001.2197.
Anti-Her-2/neu antibody is known to induce apoptosis in HER-2/neu overexpressing breast cancer cells. However, exact regulatory mechanisms mediating and controlling this phenomenon are still unknown. In the present study, we have investigated the effect of anti-Her-2/neu antibody on apoptosis of HER-2/neu overexpressing human breast cancer cell lines SK-BR-3, HTB-24, HTB-25, HTB-27, HTB-128, HTB-130 and HTB-131 in relation to p53 genotype and bcl-2 status. SK-BR-3, HTB-24, HTB-128 and HTB-130 cells exhibited mutant p53, whereas wild type p53 was found in HTB-25, HTB-27 and HTB-131 cells. All seven cell lines weakly expressed bcl-2 protein (10-20%). Anti-Her-2/neu antibody, irrespective of p53 and bcl-2 status, induced apoptosis in all 7 cell lines dose- and time-dependently and correlated with Her-2/neu overexpression. In addition, incubation of cell lines with anti-Her-2/neu antibody did not alter p53 or bcl-2 expression. Anti-HER-2/neu antibody did not induce apoptosis in HER-2/neu negative HBL-100 and HTB-132 cell lines. Our results indicate that within the panel of tested breast cancer cell lines, anti-Her-2/neu antibody-induced apoptosis was independent from the presence of intact p53.
已知抗Her-2/neu抗体可诱导HER-2/neu过表达的乳腺癌细胞发生凋亡。然而,介导和控制这一现象的确切调控机制仍不清楚。在本研究中,我们研究了抗Her-2/neu抗体对HER-2/neu过表达的人乳腺癌细胞系SK-BR-3、HTB-24、HTB-25、HTB-27、HTB-128、HTB-130和HTB-131凋亡的影响,这些细胞系与p53基因型和bcl-2状态有关。SK-BR-3、HTB-24、HTB-128和HTB-130细胞表现出p53突变,而在HTB-25、HTB-27和HTB-131细胞中发现野生型p53。所有七个细胞系均弱表达bcl-2蛋白(10%-20%)。抗Her-2/neu抗体,无论p53和bcl-2状态如何,均能剂量和时间依赖性地诱导所有7个细胞系发生凋亡,且与Her-2/neu过表达相关。此外,用抗Her-2/neu抗体孵育细胞系不会改变p53或bcl-2的表达。抗HER-2/neu抗体不会诱导HER-2/neu阴性的HBL-100和HTB-132细胞系发生凋亡。我们的结果表明,在测试的乳腺癌细胞系中,抗Her-2/neu抗体诱导的凋亡与完整p53的存在无关。